Prolonged neoadjuvant combined androgen blockade leads to a further reduction of prostatic tumor volume: Three versus six months of endocrine therapy

1999-03-01

Urology , Volume 53 - Issue 3 p. 523- 529

Additional Metadata
Persistent URL	doi.org/10.1016/S0090-4295(98)00542-1, hdl.handle.net/1765/56022
Journal	Urology
Organisation	Department of Pathology
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	van der Kwast, T., Têtu, B., Candas, B., Gomez, J.-L., & Cusan, L. (1999). Prolonged neoadjuvant combined androgen blockade leads to a further reduction of prostatic tumor volume: Three versus six months of endocrine therapy. Urology, 53(3), 523–529. doi:10.1016/S0090-4295(98)00542-1

Publication